D-0521-2025 Class II Ongoing

Recalled by ACCORD HEALTHCARE, INC. — Raleigh, NC

FDA drug recall D-0521-2025 was initiated by ACCORD HEALTHCARE, INC. on Jun 20, 2025 and is designated Class II. Reason for recall: Subpotent Drug: Assay below the approved specification The recall status is ongoing. Affected quantity: 9,739 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 23, 2025
Initiation Date
Jun 20, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,739 bottles

Product description

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17

Reason for recall

Subpotent Drug: Assay below the approved specification

Distribution pattern

Nationwide in the USA

Code information

Lot #D2300092, Exp Date: 12/31/2025; Lot #D2400722, Exp Date: 03/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0521-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0521-2025. Report a data issue: hello@regdatalab.com.